JP2014505655A5 - - Google Patents

Download PDF

Info

Publication number
JP2014505655A5
JP2014505655A5 JP2013530433A JP2013530433A JP2014505655A5 JP 2014505655 A5 JP2014505655 A5 JP 2014505655A5 JP 2013530433 A JP2013530433 A JP 2013530433A JP 2013530433 A JP2013530433 A JP 2013530433A JP 2014505655 A5 JP2014505655 A5 JP 2014505655A5
Authority
JP
Japan
Prior art keywords
peptide
seq
chimeric
peptide according
amino acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013530433A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014505655A (ja
JP6073230B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/053764 external-priority patent/WO2012050921A2/en
Publication of JP2014505655A publication Critical patent/JP2014505655A/ja
Publication of JP2014505655A5 publication Critical patent/JP2014505655A5/ja
Application granted granted Critical
Publication of JP6073230B2 publication Critical patent/JP6073230B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013530433A 2010-09-28 2011-09-28 Nd2ペプチドおよび神経疾患の治療方法 Expired - Fee Related JP6073230B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US38743910P 2010-09-28 2010-09-28
US61/387,439 2010-09-28
PCT/US2011/053764 WO2012050921A2 (en) 2010-09-28 2011-09-28 Nd2 peptides and methods of treating neurological disease

Publications (3)

Publication Number Publication Date
JP2014505655A JP2014505655A (ja) 2014-03-06
JP2014505655A5 true JP2014505655A5 (enExample) 2016-02-25
JP6073230B2 JP6073230B2 (ja) 2017-02-01

Family

ID=45938878

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013530433A Expired - Fee Related JP6073230B2 (ja) 2010-09-28 2011-09-28 Nd2ペプチドおよび神経疾患の治療方法

Country Status (15)

Country Link
US (1) US9073976B2 (enExample)
EP (1) EP2621945B1 (enExample)
JP (1) JP6073230B2 (enExample)
KR (1) KR101893473B1 (enExample)
CN (1) CN103282379B (enExample)
AU (1) AU2011314074B2 (enExample)
BR (1) BR112013007557A2 (enExample)
CA (1) CA2812948C (enExample)
DK (1) DK2621945T3 (enExample)
IL (1) IL225464B (enExample)
MX (1) MX343366B (enExample)
RU (1) RU2607033C2 (enExample)
SG (1) SG189104A1 (enExample)
UA (1) UA114592C2 (enExample)
WO (1) WO2012050921A2 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA123820C2 (uk) * 2014-05-28 2021-06-09 Ноно Інк. Хлоридна сіль пептиду tat-nr2b9c
CN109072242A (zh) * 2016-02-23 2018-12-21 科罗拉多州立大学董事会法人团体 用于治疗神经损伤的基于肽的方法
US11229675B2 (en) * 2016-04-27 2022-01-25 Biocells (Beijing) Biotech Co., Ltd. Therapeutic peptides for excitatory neurotoxicity-related injuries
GB201620611D0 (en) 2016-12-05 2017-01-18 Univ Of Lancaster Treatment of neurological diseases
CN112679595B (zh) * 2020-04-10 2022-11-01 南京市儿童医院 脑源肽或融合肽在新生儿缺氧缺血性脑损伤药物中的应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2281129T3 (es) * 1997-08-12 2007-09-16 Bristol-Myers Squibb Company Canales de potasio kcnq y procedimientos para su modulacion.
CA2368229A1 (en) * 1999-03-19 2000-09-28 Craig A. Rosen 50 human secreted proteins
NZ527302A (en) * 2001-01-05 2006-10-27 Abgenix Inc Antibodies to insulin-like growth factor I receptor
AU2003262642B2 (en) * 2002-08-14 2010-06-17 Vertex Pharmaceuticals Incorporated Protein kinase inhibitors and uses thereof
EP1551424B1 (en) * 2002-09-04 2015-07-01 Arrowhead Research Corporation Treatment of chronic neuropathic pain by admistration of dsrna
US8003609B2 (en) * 2004-03-30 2011-08-23 The Hospital For Sick Children Method for ameliorating pain by modification of NMDA receptors through inhibition of Src
US7425540B2 (en) * 2004-03-30 2008-09-16 The Hospital For Sick Children Method for modification of NMDA receptors through inhibition of Src
EP1912680B1 (en) * 2005-06-15 2014-11-26 The Ohio State University Research Foundation Her-2 peptides
ES2446292T3 (es) * 2007-03-02 2014-03-07 Nono Inc. Tratamiento del accidente cerebrovascular y otras enfermedades sin inhibir los canales de calcio de tipo N

Similar Documents

Publication Publication Date Title
EP3371207B1 (en) Nucleic acids, peptides and methods
Rai Peptide and protein mimetics by retro and retroinverso analogs
JP2011526886A5 (enExample)
EP2570430A3 (en) Peptide vaccines with Seq ID No: 78, 41, 44, 46 or 48 for cancers expressing tumor-associated antigens
WO2010111617A4 (en) Parathyroid hormone peptides and parathyroid hormone-related protein peptides and methods of use
JP2010537638A5 (enExample)
JP2014501510A5 (enExample)
JP2013518115A5 (enExample)
JP2010024250A (ja) 生物学的エフェクターの細胞内送達
JP2012082206A5 (enExample)
EP2476697A3 (en) Peptide vaccines for cancers expressing MPHOSPH1 or DEPDC1 polypeptides
JP2011501652A5 (enExample)
IN2012DN03368A (enExample)
JP2014506450A5 (enExample)
JP2018538356A5 (enExample)
CN117279618A (zh) 用于靶标分子的选择性耗竭的组合物和方法
JP2011509093A5 (enExample)
MX2009007261A (es) Vacuna de peptido foxp3.
WO2011048503A3 (en) Peptides that bind the alpha-fetoprotein (afp) receptor and uses thereof
MX381786B (es) Gen insecticida variante axmi115 y métodos para utilizarlo.
JP2022509258A5 (enExample)
SA515360713B1 (ar) مـشـتـق ببـتـيد انتحـائي للأنسـولين ذي شـحنة مـعـدلة عـنـد N-Terminal
JP2014505010A5 (enExample)
DE602005025141D1 (de) In Zellen eindringende Peptide als Träger für Moleküle
WO2015083816A1 (ja) 新規nk3受容体アゴニスト